Noticias de CNSP_US

Noticias del mercado

Últimas noticias sobre CNSP_US — 164 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CNSP_US ✕ 164 resultados
20/05/2026 CNSP_US — Investing.com ES ← EN
La directora de CNS Pharmaceuticals, Faith L. Charles, compra acciones por valor de 34.001 dólares Por Investing.com

CNS Pharmaceuticals director Faith L. Charles buys $34,001 in stock By Investing.com

20/05/2026 CNSP_US — GuruFocus ES ← EN
Compra de información privilegiada: Faith Charles adquiere acciones de CNS Pharmaceuti

Insider Buying: Faith Charles Acquires Shares of CNS Pharmaceuti

20/05/2026 CNSP_US — Investing.com
CNS Pharmaceuticals director Faith L. Charles buys $34,001 in stock By Investing.com
20/05/2026 CNSP_US — Quiver Quantitative
CNSP | CNS Pharmaceuticals, Inc. Common Insider Trading
20/05/2026 CNSP_US — Investing.com ES ← EN
La directora de CNS Pharmaceuticals, Faith L. Charles, compra acciones por valor de 34.001 dólares Por Investing.com

CNS Pharmaceuticals director Faith L. Charles buys $34,001 in stock By Investing.com

20/05/2026 CNSP_US — Investing.com ES ← EN
La directora de CNS Pharmaceuticals, Faith L. Charles, compra acciones por valor de 34.001 dólares

CNS Pharmaceuticals director Faith L. Charles buys $34,001 in stock

20/05/2026 CNSP_US — Weatherford Democrat ES ← EN
El director ejecutivo de CNS Pharmaceuticals, Rami Levin, participa en el segmento Virtual Investor CEO Connect que destaca el reciente progreso de la transformación estratégica de la empresa

CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress

20/05/2026 CNSP_US — Corsicana Daily Sun ES ← EN
El director ejecutivo de CNS Pharmaceuticals, Rami Levin, participa en el segmento Virtual Investor CEO Connect que destaca el reciente progreso de la transformación estratégica de la empresa

CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress

20/05/2026 CNSP_US — The Daily Corinthian ES ← EN
El director ejecutivo de CNS Pharmaceuticals, Rami Levin, participa en el segmento Virtual Investor CEO Connect que destaca el reciente progreso de la transformación estratégica de la empresa

CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress

20/05/2026 CNSP_US — guardonline.com
CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress
20/05/2026 CNSP_US — ACCESS Newswire ES ← EN
El director ejecutivo de CNS Pharmaceuticals, Rami Levin, participa en el segmento Virtual Investor CEO Connect que destaca el reciente progreso de la transformación estratégica de la empresa

CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress

20/05/2026 CNSP_US — The Globe and Mail ES ← EN
El director ejecutivo de CNS Pharmaceuticals, Rami Levin, participa en el segmento Virtual Investor CEO Connect que destaca el reciente progreso de la transformación estratégica de la empresa

CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress

20/05/2026 CNSP_US — Yahoo Finance
CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress
20/05/2026 CNSP_US — Investing.com
CNS Pharmaceuticals director Faith L. Charles buys $34,001 in stock
20/05/2026 CNSP_US — Stock Titan
[Form 4] CNS Pharmaceuticals, Inc. Insider Trading Activity
20/05/2026 CNSP_US — GuruFocus
Insider Buying: Faith Charles Acquires Shares of CNS Pharmaceuti
20/05/2026 CNSP_US — Bluefield Daily Telegraph
CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress
19/05/2026 CNSP_US — Stock Titan
CNS Pharmaceuticals (CNSP) registers 9.79M shares including prefunded warrants
18/05/2026 CNSP_US — RTTNews ES ← EN
cnspharmacy inc Fechas de resultados

cns pharmaceuticals inc Earnings dates

18/05/2026 CNSP_US — MarketScreener
CNS Pharmaceuticals, Inc. announced that it has received $22.515858 million in funding from ADAR1 Capital Management, LLC, Ikarian Capital, LLC, Stonepine Capital Management LLC, Nazare Partners and other investors

Página 2 de 9

keyboard_arrow_up